- What are the top holdings of PRME?
- Prime Medicine, Inc. holds — securities in total. The largest positions and their portfolio weights are listed on the Holdings tab.
- How many holdings does PRME have?
- PRME holds — positions as reported by the fund's most recent disclosure.
- What sectors does PRME invest in?
- Prime Medicine, Inc. (PRME) allocates across the sectors shown above. The largest exposure tops the list; the rest follow in descending weight order.
- What sector is PRME most exposed to?
- PRME's full sector breakdown is on the Sectors tab. The largest sector weight is shown there along with the rest of the allocation.
- Is PRME a US-only fund?
- The country allocation card on this page shows PRME's geographic exposure. Funds with > 95% US weight are effectively US-only; international or global funds will show meaningful weights across multiple countries.
- What does PRME invest in?
- Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.
